Internal Medicine Meeting Recordings
Renowned faculty will discuss the diagnosis of prediabetes and diabetes, including atypical forms of diabetes in adults. Faculty will review the role of lifestyle interventions as well as appropriate indications and practical use of weight loss medications. The growing role of diabetes technology will be addressed. The risks and benefits of new insulin and noninsulin pharmacologic therapies will also be presented. The role of diabetes medications, cholesterol-lowering agents, and blood pressure control to reduce cardiometabolic risk will be thoroughly discussed.
This extensive collection of virtual lectures will cover:
- Current guidelines for the management of patients with diabetes and prediabetes.
- Guidance on the evaluation, classification, and treatment of diabetes, including less common atypical forms of diabetes.
- New insulin products and diabetes technology (including new pens, pumps, and sensors) available for patients with type 1 and 2 diabetes.
- The rapidly expanding role of noninsulin therapeutics in the management of type 2 diabetes.
- The role of nutrition and medication use for weight management in patients with obesity and diabetes.
- The prevention and treatment of cardiovascular disease in patients with diabetes.
- A review of questions and challenges that arise in practice.
Course Director
Irl B. Hirsch, MD, MACP
Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, Seattle, WA
Copyright 2025 American College of Physicians. All Rights Reserved.
CME/MOC:
Up to 6.75
AMA PRA Category 1 Credits ™ and MOC Points
Expires June 02, 2028
active
Cost:
Discounted to Members
Format:
Video Recordings
Product:
Internal Medicine Meeting Recordings
ACP's Internal Medicine Meeting Recording packages include video and slide presentations from a curated selection of popular and highly rated sessions delivered during or derived from the ACP Internal Medicine Meeting. Trusted, timely content in general internal medicine and the subspecialties is presented by expert faculty; CME and MOC available.
Disclosures
The individuals listed below have relevant financial relationships with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No other individuals in control of content for this activity have any relevant financial relationships to disclose. All relevant financial relationships have been mitigated.
Aleppo Grazia, MD, FACP
Grant/Contract: AbbVie, Fractyl, Bayer Healthcare Pharmaceuticals Inc, Insulet Corporation, MannKind Corporation, Dexcom Inc, Tandem Diabetes Care Inc
Consultant: Dexcom Inc, Insulet Corporation
Travel: Eli Lilly and Company
Irl Hirsch, MD, MACP
Grant/Contract: MannKind Corporation, Tandem Diabetes Care Inc
Consultant: Abbott Diabetes Care, Gwave, Roche Diabetes Care Inc
Janet McGill, MD FACP
Grant/Contract: Medtronic MiniMed Inc, Novo Nordisk
Consultant: Bayer Healthcare, Eli Lilly and Company, MannKind Corporation
Savitha Subramanian, MD
Consultant: Abbott Diabetes Care, Ionis Pharmaceuticals
Accreditation
The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Physicians designates this enduring material for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Release Date: 6/3/2025
Expiration Date: 6/2/2028